MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

Profile

Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
136.75M
P/E Ratio
N/A
Total Cash
99.83M
Projected Growth
N/A
Total Debt
9.4M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

LXEO
Capitalization
137M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
99.8M
Total Cash/Share
3.01
Total Debt
9.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
88.1M
P/B Ratio
1.55
Cash Flow
N/A
Earnings
-3.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
3.42
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-107.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-64.51
Shares Held By Institutions
154M
Shares Outstanding - Current
33.2M
Total Liabilities
37.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-37.386
View a ticker or compare two or three
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com